These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 202757)

  • 1. Radiobiological inactivation of Epstein-Barr virus.
    Henderson E; Heston L; Grogan E; Miller G
    J Virol; 1978 Jan; 25(1):51-9. PubMed ID: 202757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference.
    Miller G; Robinson J; Heston L; Lipman M
    IARC Sci Publ (1971); 1975; (11 Pt 1):395-408. PubMed ID: 190145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
    Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E
    Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.
    Miller G; Lipman M
    J Exp Med; 1973 Dec; 138(6):1398-412. PubMed ID: 4357683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of transforming Epstein-Barr virus (EBV) from EBV-genome-positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA.
    Stoerker J; Glaser R
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1726-9. PubMed ID: 6300871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.
    Desgranges C; Lenoir G; de-Thé G; Seigneurin JM; Hilgers J; Dubouch P
    Biomedicine; 1976 Dec; 25(9):349-52. PubMed ID: 187263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony morphology, cell growth and viral radiosensitivity as parameters for detecting strain differences in Epstein-Barr virus (EBV).
    Levitt M; Shungu D; Henderson E
    Int J Cancer; 1980 Oct; 26(4):509-15. PubMed ID: 6265384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Miller G; Robinson J; Heston L; Lipman M
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4006-10. PubMed ID: 4372601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell reactivation of uv- and X-ray-damaged herpes simplex virus by Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines.
    Henderson EE; Long WK
    Virology; 1981 Dec; 115(2):237-48. PubMed ID: 6274084
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a region of the Epstein-Barr virus (B95-8) genome required for transformation.
    Stoerker J; Holliday JE; Glaser R
    Virology; 1983 Aug; 129(1):199-206. PubMed ID: 6310878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
    Takimoto T; Iwawaki J; Tanaka S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.